Veraart, J.K.E.; Vos, C.F.; Punt, N.C.; Visser, D.; Wessels, M.A.; Smith-Apeldoorn, S.Y.; Kamphuis, J.; Schoevers, R.A.; Touw, D.J.
Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study. Pharmaceuticals 2025, 18, 627.
https://doi.org/10.3390/ph18050627
AMA Style
Veraart JKE, Vos CF, Punt NC, Visser D, Wessels MA, Smith-Apeldoorn SY, Kamphuis J, Schoevers RA, Touw DJ.
Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study. Pharmaceuticals. 2025; 18(5):627.
https://doi.org/10.3390/ph18050627
Chicago/Turabian Style
Veraart, Jolien K. E., Cornelis F. Vos, Nieko C. Punt, Dylan Visser, Mireille A. Wessels, Sanne Y. Smith-Apeldoorn, Jeanine Kamphuis, Robert A. Schoevers, and Daan J. Touw.
2025. "Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study" Pharmaceuticals 18, no. 5: 627.
https://doi.org/10.3390/ph18050627
APA Style
Veraart, J. K. E., Vos, C. F., Punt, N. C., Visser, D., Wessels, M. A., Smith-Apeldoorn, S. Y., Kamphuis, J., Schoevers, R. A., & Touw, D. J.
(2025). Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study. Pharmaceuticals, 18(5), 627.
https://doi.org/10.3390/ph18050627